Literature DB >> 1407276

The properties of cultured fetal human and rat brain tissue and its use as grafts for the relief of the parkinsonian syndrome.

A M Walters1, D J Clarke, H F Bradford, G M Stern.   

Abstract

Primary cultures were derived from human fetal ventral mesencephalon and cerebral cortex at 7-11 weeks gestation, and from fetal rat mesencephalon and cortex at embryonic day 14-15. Immunohistochemical analysis of the mesencephalic cultures using antibodies to tyrosine hydroxylase (TH) showed between 0.1-0.5% of human cells to be TH positive and 0.1-1% of rat cells to be TH positive. HPLC analysis of extracts from the cultures showed that they had the ability to synthesise and store dopamine. Implantation of the cultured human and rat mesencephalic tissue into a 6-hydroxydopamine rat model of Parkinson's disease produced marked recovery from amphetamine induced rotational asymmetry in the recipient rats, but no such recovery was observed following implantation of cortical cultures. Histological examination demonstrated the presence of surviving human mesencephalic and cortical grafts at least 6 months after implantation. Implants of cultured fetal rat tissue were less obviously but still significantly effective in these experiments. These rat tissue grafts were detectable for periods of at least 6-8 weeks by histological staining.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1407276     DOI: 10.1007/bf00993265

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  22 in total

Review 1.  Grafting genetically modified cells to the brain: conceptual and technical issues.

Authors:  F H Gage; L J Fisher; H A Jinnah; M B Rosenberg; M H Tuszynski; T Friedmann
Journal:  Prog Brain Res       Date:  1990       Impact factor: 2.453

2.  Fetal homotransplants (ventral mesencephalon and adrenal tissue) to the striatum of parkinsonian subjects.

Authors:  I Madrazo; R Franco-Bourland; F Ostrosky-Solis; M Aguilera; C Cuevas; C Zamorano; A Morelos; E Magallon; G Guizar-Sahagun
Journal:  Arch Neurol       Date:  1990-12

3.  Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up.

Authors:  O Lindvall; S Rehncrona; P Brundin; B Gustavii; B Astedt; H Widner; T Lindholm; A Björklund; K L Leenders; J C Rothwell; R Frackowiak; D Marsden; B Johnels; G Steg; R Freedman; B J Hoffer; A Seiger; M Bygdeman; I Strömberg; L Olson
Journal:  Arch Neurol       Date:  1989-06

4.  Light-microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat brain. II. Late ontogeny.

Authors:  L A Specht; V M Pickel; T H Joh; D J Reis
Journal:  J Comp Neurol       Date:  1981-06-20       Impact factor: 3.215

5.  Intracerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism.

Authors:  R H Schmidt; A Björklund; U Stenevi; S B Dunnett; F H Gage
Journal:  Acta Physiol Scand Suppl       Date:  1983

6.  Long-term cultivation of cryopreserved human fetal brain cells in a chemically defined medium.

Authors:  G Haselbacher; P Groscurth; U Otten; H Vedder; U Lutz; P Sonderegger; A Bulatko; N Greeff; R Humbel
Journal:  J Neurosci Methods       Date:  1989-11       Impact factor: 2.390

7.  Survival and function of dissociated rat dopamine neurones grafted at different developmental stages or after being cultured in vitro.

Authors:  P Brundin; G Barbin; R E Strecker; O Isacson; A Prochiantz; A Björklund
Journal:  Brain Res       Date:  1988-04-01       Impact factor: 3.252

8.  Characterization of fetal human brain cultures. Development of a potential model for selectively purifying human glial cells in culture.

Authors:  J T Rutka; J R Giblin; R Balkissoon; D Wen; C A Myatt; J R McCulloch; M L Rosenblum
Journal:  Dev Neurosci       Date:  1987       Impact factor: 2.984

9.  Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year.

Authors:  C R Freed; R E Breeze; N L Rosenberg; S A Schneck; T H Wells; J N Barrett; S T Grafton; S C Huang; D Eidelberg; D A Rottenberg
Journal:  Arch Neurol       Date:  1990-05

10.  Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release.

Authors:  P Brundin; R E Strecker; H Widner; D J Clarke; O G Nilsson; B Astedt; O Lindvall; A Björklund
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

View more
  1 in total

1.  Defining the unknowns for cell therapies in Parkinson's disease.

Authors:  Emma L Lane; Mariah J Lelos
Journal:  Dis Model Mech       Date:  2022-09-27       Impact factor: 5.732

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.